EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pathobiology of Mycobacterium fortuitum and NTM biofilms: spotlight on emerging therapeutic horizons

Ayushi Sharma, Sourav Kumar, Rahul Shrivastava

Advances in Applied Microbiology · 2026 · 113-140

DOI: 10.1016/bs.aambs.2026.04.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Applied Microbiology, 2026. Verfasst von Ayushi Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, India; Department of…. Hauptthemen laut MEDLINE: Biofilms, Mycobacterium fortuitum, Mycobacterium Infections, Nontuberculous, Nontuberculous Mycobacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapidly growing nontuberculous mycobacteria (NTM) are emerging pathogens that are well-known entities behind pulmonary, extra-pulmonary, cutaneous, subcutaneous, as well as systemic and disseminated infections. Mycobacterium fortuitum is an important human pathogenic NTM. It is a routine nosocomial contaminant capable of forming resilient biofilms that enhance its resistance to antibiotics and disinfectants and contribute to persistent healthcare-associated infections. Moreover, varying symptoms of M. fortuitum infections, long duration therapeutics, and lack of a standardized drug regimen underscores medical significance of the pathogen. Limited knowledge regarding M. fortuitum pathogenesis, however, entices research investigating M. fortuitum planktonic as well as the biofilm phenotype. The review article aims to gather data about the prevalence and clinical significance of NTM in general, with special emphasis on M. fortuitum. It further delves into the biofilm aspect of the pathogen and examines current therapeutic strategies against NTM infections and diseases. Emerging horizons in NTM therapeutics, including repurposing antitubercular drugs, bacteriophage therapy, photodynamic therapy, and advancements in molecular diagnostic techniques are being explored to combat NTM infections. In addition, innovative treatments specifically targeting NTM biofilms, such as combination therapies, liposomal formulations, thiopeptide antibiotics, monoclonal antibodies, and inhibitors of the DosRS system, are under investigation. The concluding section of the article emphasizes the necessity for future research to delve into molecular mechanisms underlying biofilm formation and maintenance, develop targeted therapies, and refine diagnostic tools to effectively manage and treat NTM infections. Collectively, the information will be helpful to the researchers working on strategies and treatments to combat NTM infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsMycobacterium fortuitumMycobacterium Infections, NontuberculousNontuberculous MycobacteriaHumansAnti-Bacterial AgentsAntitubercular Agents

Stichwörter der Autor:innen

Anti-NTM drugsBiofilmMycobacterium fortuitumNontuberculous mycobacteria (NTM)PathogenesisPulmonary disease

Substanzen

Anti-Bacterial AgentsAntitubercular Agents

Autor:innen und Institutionen

  • Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, India; Department of Biochemistry, Postgraduate Institute of Medical Education and Researc…
  • Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, India.
  • Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, India. Electronic address: juit.rahul@gmail.com.

Zitieren

APA

Sharma, A., Kumar, S., & Shrivastava, R. (2026). Pathobiology of Mycobacterium fortuitum and NTM biofilms: spotlight on emerging therapeutic horizons. Advances in Applied Microbiology, 113-140. https://doi.org/10.1016/bs.aambs.2026.04.002

Vancouver

Sharma A, Kumar S, Shrivastava R. Pathobiology of Mycobacterium fortuitum and NTM biofilms: spotlight on emerging therapeutic horizons. Advances in Applied Microbiology. 2026:113-140. doi:10.1016/bs.aambs.2026.04.002

BibTeX
@article{Sharma2026,
  author = {Sharma, Ayushi and Kumar, Sourav and Shrivastava, Rahul},
  title = {Pathobiology of Mycobacterium fortuitum and NTM biofilms: spotlight on emerging therapeutic horizons},
  journal = {Advances in Applied Microbiology},
  year = {2026},
  pages = {113--140},
  doi = {10.1016/bs.aambs.2026.04.002}
}
Kostenlos starten →